LoadingLoadingLoadingNet selling: insiders sold $2.1M and bought $61K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
Qube Research
$79.9M
added
Point72
$30.2M
added
Sells/Trims (1)
Millennium
$165.0M
trimmed
No tracked top-trader positions in DAR as of Oct 24, 09:27 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Jul 30, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.48 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 23, 2026
EPS expected
$1.61 to $2.08
Revenue expected
10 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $2.49 / $1.48Yahoo Finance | +68.35% beat | $1.72B No estimate | Unavailable |
| Mar 31, 2026 | Apr 30, 2026 | $0.86 / $0.61Yahoo Finance | +40.74% beat | $1.55B No estimate | Unavailable |
| Dec 31, 2025 | Feb 11, 2026 | $0.75 / $0.35Yahoo Finance | +112.96% beat | $1.72B No estimate | Unavailable |
| Sep 30, 2025 | Oct 23, 2025 | $0.16 / $0.22Yahoo Finance | -28.69% miss | $1.56B No estimate | Unavailable |
| Jun 30, 2025 | Jul 24, 2025 | $0.17 / $0.18Alpha Vantage | -5.56% miss | $1.48B No estimate | Unavailable |
| Mar 31, 2025 | Apr 24, 2025 | -$0.12 / $0.16Alpha Vantage | -$0.28 miss | $1.38B No estimate | Unavailable |
| Dec 31, 2024 | Feb 6, 2025 | $0.66 / $0.48Alpha Vantage | +37.50% beat | $1.42B No estimate | Unavailable |
| Sep 30, 2024 | Oct 24, 2024 | $0.21 / $0.38Alpha Vantage | -44.74% miss | $1.42B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.56B | $1.72B | $1.55B | $1.72B |
| Cost of what it sold | $1.30B | $1.42B | $1.28B | $916.1M |
| Gross profit | $261.2M | $298.4M | $274.0M | $808.0M |
| What it spent | ||||
| Sales and admin | $139.6M | $151.9M | $149.1M | $150.9M |
| Other operating costs | $5.7M | $1.9M | — | — |
| Total operating expenses | $145.3M | $153.9M | $149.1M | $150.9M |
| What was left | ||||
| Operating profit | $115.9M | $144.5M | $124.9M | $657.1M |
| Interest on debt | $56.9M | $55.5M | $54.1M | $163.8M |
| Profit before tax | $19.8M | $47.9M | $175.7M | $499.9M |
| Tax | -$1.2M | -$11.0M | $38.6M | $110.6M |
| Net profit | $19.4M | $56.9M | $134.3M | $387.3M |
| EBITDA | $200.8M | $242.9M | $360.7M | $682.4M |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Darling Ingredients Inc. (DAR) Stock forecasts
BullishOct 21Stephens raises target for Darling Ingredients stock to USD 80.00
BullishOct 20A collagen ingredient concentrates targeted compounds at over 100 times standard levels
BullishOct 20Darling Ingredients Introduces Nextida® NxCogni™, the First Targeted Collagen Peptide Designed to Support Clarity and Cognitive Resilience
BullishOct 20Darling Ingredients (DAR) Pauses After Recent Moves But Is The Undervalued Story Still Intact
Leans bullishOct 18Darling Ingredients (DAR) Pauses After Recent Moves But Is The Undervalued Story Still Intact
Leans bullishOct 18JPMorgan raises target for Darling Ingredients stock to USD 83.00
BullishOct 17Darling Ingredients Inc. (DAR) Options Chain
NeutralOct 17
